Investigations for Suspected Rheumatoid Arthritis
Order anti-citrullinated protein antibodies (ACPA/anti-CCP) and rheumatoid factor (RF) as your primary serologic tests, along with C-reactive protein (CRP) and baseline X-rays of hands, wrists, and feet—these form the core diagnostic workup for suspected RA. 1, 2
Essential Laboratory Tests
Serologic Markers
- Test both RF and ACPA (anti-CCP) in all patients presenting with synovitis, as these are the cornerstone autoantibodies for RA diagnosis 3, 1
- ACPA has superior specificity (90%) with moderate sensitivity (60%), making it particularly valuable for confirming the diagnosis 3
- RF has comparable sensitivity (60-80%) but lower specificity (70%), increasing to approximately 80% with prolonged disease 3
- Negative RF and ACPA do not exclude RA—30-40% of RA patients are seronegative 2, 4
- High-positive RF or high-positive ACPA scores 3 points in the 2010 ACR/EULAR classification criteria, while low-positive results score 2 points 3
Acute Phase Reactants
- Measure CRP at baseline for both diagnosis and prognosis 3, 1
- CRP is preferred over ESR because it is simpler, more reliable, and not age-dependent 3
- Measuring both CRP and ESR offers no additional clinical value 3
- Abnormal CRP or ESR scores 1 point in the classification criteria 3
- Note that 40% of RA patients have normal acute phase reactants, so normal values do not exclude the diagnosis 4
Imaging Studies
Plain Radiography
- Obtain X-rays of hands, wrists, and feet at baseline as the initial imaging method of choice 3, 1
- The presence of erosions is predictive for RA development and disease persistence, scoring 5 points in classification criteria if erosions are present 3
- Repeat X-rays within 1 year to assess progression 3
- Early radiographic features include soft tissue swelling and juxtaarticular osteoporosis 5
Advanced Imaging (When Indicated)
- MRI of hands and wrists can be considered when RA is suspected but clinical findings are inconclusive 3, 1
- MRI can identify synovitis, bone edema, and erosions not evident on clinical examination or plain films 3
- Ultrasound can detect synovial thickening even within finger joints, improving early assessment 5
- Routine use of MRI and ultrasound is not recommended due to insufficient evidence for diagnosis or prognosis in undifferentiated arthritis 3
Clinical Assessment Components
Joint Examination
- Perform a 28-joint count including proximal interphalangeal joints (1st-5th), metacarpophalangeal joints (1st-5th), wrists, elbows, shoulders, and knees bilaterally 3
- Document the number of tender and swollen joints systematically 3
- Small joint involvement (1-3 joints) scores 2 points, 4-10 small joints scores 3 points, and >10 joints including at least 1 small joint scores 5 points 3
Patient-Reported Outcomes
- Assess morning stiffness duration (>30 minutes suggests inflammatory arthritis) 3
- Measure pain using visual analog scales 3
- Obtain patient Global Assessment of Disease Activity score 3
- Evaluate functional status with Health Assessment Questionnaire Disability Index 3
Additional Baseline Tests
- Complete blood count with differential to assess for anemia and other hematologic abnormalities 6
- Renal and hepatic function tests before initiating disease-modifying therapy 6
- Consider HLA-B27 testing only in specific clinical settings if axial or entheseal involvement suggests spondyloarthropathy rather than RA 3
Critical Pitfalls to Avoid
- Do not delay referral to rheumatology based on negative RF or normal acute phase reactants—refer urgently if small joints of hands/feet are affected, multiple joints are involved, or symptoms persist ≥3 months 1, 2, 7
- Do not routinely perform synovial biopsy; reserve this for persistent monoarthritis when differential diagnosis is unclear 3
- Do not order genetic testing routinely, as no genetic test can be recommended for standard RA diagnosis 3
- Remember that distal interphalangeal joints, sacroiliac joints, and lumbar spine are rarely involved in RA—their involvement suggests alternative diagnoses 5
Scoring for Classification
A score of ≥6/10 on the 2010 ACR/EULAR criteria establishes definite RA classification in patients with at least one joint showing definite clinical synovitis not better explained by another disease 3. The scoring includes:
- Joint involvement (0-5 points based on number and size of joints)
- Serology (0-3 points for RF and ACPA results)
- Acute phase reactants (0-1 point for abnormal CRP or ESR)
- Symptom duration (1 point if ≥6 weeks) 3